Naturopathic Doctors Look Bad After California Woman Dies From Turmeric Injection

Forbes, 27 March 2017
Author: Britt Marie Hermes
“A San Diego woman recently died of cardiopulmonary arrest after receiving an intravenous injection of turmeric. Reliable evidence for using turmeric for any medical condition is scanty at best. There have been preliminary studies on intravenous turmeric in combination with conventional chemotherapy, but no firm conclusions can be drawn. In other words, intravenous turmeric poses unnecessary risks. This is likely the result of naturopathic education blurring the line between treatments backed by good evidence and practices using “natural” substances that turn profits.”
Find article here.

Trump’s Promise To Rein In Drug Prices Could Open Floodgate To Importation Laws

KHN, 22 March 2017
Author: Rachel Bluth
“With prescription drug prices soaring, an old idea is gaining fresh traction: allowing Americans to buy medicines from foreign pharmacies at far lower prices. A new bill in Congress to allow the practice would modify previous safety standards and remove a barrier that proved insurmountable in past attempts to enable progress.”
Find article here.

In Pausing Human Research On Zika, Medical Ethicists Acknowledge A Dark Past

Wbur, 21 March 2017
Author: Paul C. McLean
“This was the proposal: Deliberately infect a small group of consenting adults with the Zika virus to learn about the disease and speed up the search for a vaccine. The need is clear. Zika is an emerging global threat to public health. The NIH called for an ethics consultation and asked two essential questions: Can a Zika “human challenge” study be ethically justified? If so, under what conditions? The panel’s answer, in short, was this: The research could be justified, but conditions must be met. Their assessment epitomizes both the grand purpose of bioethics and the broad frustration with it.”
Find article here.”

9 Deaths Are Linked to Rare Cancer From Breast Implants

NYT, 21 March 2017
Author: Denise Grady
“A rare cancer first linked to breast implants in 2011 has now been associated with nine deaths, the Food and Drug Administration said Tuesday. As of Feb. 1, the agency had received a total of 359 reports of the cancer associated with the implants. The deaths were not caused by breast cancer, the agency said, but by a rare malignancy in the immune system, anaplastic large-cell lymphoma. The agency said it was impossible to say how many cases exist, because of limited reporting of problems and a lack of worldwide sales data on implants.”
Find article here.

Punishing medical errors won’t improve hospital safety or quality

The Conversation, 16 March 2017
Authors: Joseph Ibrahim, John McNeil
“Australian public hospitals will soon be penalised for serious errors, with the aim of improving the quality and safety of health services. The punitive measure was a core proposal in the pricing framework for Australian public hospital services presented to the Health Council of COAG (Council of Australian Governments) in March 2017. Even where the event is a clear, avoidable error, there is little if any evidence their frequency reflects the overall quality of care provided by a hospital. IPHA’s recommendations are drawn from opinion rather than empirical evidence.”
Find article here.

Some Gun Laws Tied to Lower Suicide Rates

NYT, 15 March 2017
Author: Nicholas Bakalar
“Background checks and waiting periods for gun purchases are associated with lower suicide rates. According to the National Center for Health Statistics, the national suicide rate is now 13 per 100,000, a 30-year high. Researchers found that states with universal background checks had a decrease of 0.29 suicides per 100,000 people from 2013 to 2014. Those without such laws had an average increase of 0.85.”
Find article here.

Calls for ibuprofen sale restrictions after study finds cardiac arrest risk

The Guardian, 15 March 2017
Author: Matthew Weaver
“There have been fresh calls for restrictions on the sale of the painkiller ibuprofen after another study found it heightens the risk of cardiac arrest. Taking the over-the-counter drug was associated with a 31% increased risk, researchers in Denmark found. Diclofenac, available over the counter in the UK until 2015 and still taken on prescription, raised the risk by 50%.”
Find article here.

Three women blinded by unapproved stem-cell ‘treatment’ at South Florida clinic

The Washington Post, 15 March 2017
Author: Laurie McGinley
“Three women with macular degeneration became permanently blind after undergoing an unproven stem-cell treatment touted as a clinical trial at a South Florida clinic. Medical experts said the episode raises questions about whether the government and doctors are doing enough to protect patients from the dangers of unapproved therapies.”
Find article here.

How Do We Protect Patients From False Promises In Right-To-Try Laws?

Health Affairs Blog, 14 March 2017
Author: Ellen Sigal
“Unfortunately, the current federal legislation provides almost no protections for patients. Everyone with a late-stage terminal illness like my sister deserves the chance to try an experimental therapy. However, serious changes to today’s legislative proposal are needed before this law is safe for patients.”
Find article here.

Pelvic mesh devices hit by allegations of research fraud, experimental surgery on thousands of women

SMH, 14 March 2017
Author: Joanne McCarthy
“Pelvic devices developed in Australia from the 1980s and 1990s are at the centre of a global medical scandal that includes regulatory failure, and allegations of research fraud and experimental surgery on women in multiple countries.”
Find article here.